Panic Disorder

• FDA approval · 2011-04-14
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)

  FDA approved Aurobindo Pharma Limited's original ANDA for venlafaxine hydrochloride, a generic antidepressant.

• FDA approval · 2011-04-08
  FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for clonazepam filed by Aurobindo Pharma Limited under ANDA075150.

• FDA approval · 2011-03-14
  FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approves a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling its generic product.

• FDA approval · 2011-03-04
  FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited.

• FDA approval · 2011-01-30
  FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for Paroxetine hydrochloride by Zydus Lifesciences Limited, indicating an update to the labeling or …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2010-12-14
  FDA Approved: VENLAFAXINE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approved Alembic Pharmaceuticals' generic venlafaxine via an Original Application (ANDA). It is indicated for major depressive disorder,…

• FDA approval · 2010-12-10
  FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)

  FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) submitted by NorthStar Rx LLC. This action represents an a…

• FDA approval · 2010-10-15
  FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for paroxetine hydrochloride (generic) from Zydus Lifesciences Limited, authorizing a generic paroxe…

• FDA approval · 2010-08-18
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries' generic venlafaxine hydrochloride under an Original Application. It is indicated for major depre…

• FDA approval · 2010-08-04
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Venlafaxine hydrochloride by Teva Pharmaceuticals USA, Inc.

• FDA approval · 2010-06-28
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's venlafaxine hydrochloride as an Original Application generic (ANDA). The approval enables a generic version of venlafaxi…

• FDA approval · 2010-06-27
  FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for clonazepam submitted by Teva Pharmaceuticals USA, Inc., marking an updated regulatory action for…

• FDA approval · 2010-06-25
  FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

  FDA approved a supplemental application for fluoxetine hydrochloride (fluoxetine) from QUALLENT PHARMACEUTICALS HEALTH LLC, updating the app…

• FDA approval · 2010-06-21
  FDA Approved: PAROXETINE HYDROCHLORIDE — Original Application (Oxford Pharmaceuticals, LLC)

  FDA approved Paroxetine hydrochloride as an Original Application (ANDA) generic for Oxford Pharmaceuticals, LLC.

• FDA approval · 2010-05-19
  FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for fluoxetine submitted by Teva Pharmaceuticals USA, Inc. (the snippet does not specify the exact c…

• FDA approval · 2010-04-07
  FDA Approved: VENLAFAXINE — Original Application (Aurobindo Pharma Limited)

  FDA approved Aurobindo Pharma Limited's original application for Venlafaxine hydrochloride, a generic version of venlafaxine.

• FDA approval · 2010-03-25
  FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals Inc., advancing the generic …

• FDA approval · 2010-03-25
  FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for paroxetine hydrochloride from Apotex Corp., granting approval for an additional generic product.

• FDA approval · 2010-03-22
  FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)

  FDA approved a generic version of fluoxetine hydrochloride (an SSRI) from Dr. Reddy's Laboratories Limited under an Original Application (AN…

• FDA approval · 2010-03-16
  FDA Approved: ALPRAZOLAM — Original Application (Actavis Pharma, Inc.)

  FDA approves Actavis Pharma, Inc.'s generic alprazolam through an Original Application (ANDA).

• FDA approval · 2010-03-15
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690.

• FDA approval · 2010-03-11
  FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)

  FDA approved a supplemental application submitted by BluePoint Laboratories for venlafaxine (venlafaxine hydrochloride) as a generic product…

• FDA approval · 2010-02-26
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)

  FDA approved a supplemental application for Venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited under an ANDA. This confirms reg…

• FDA approval · 2010-01-06
  FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

  FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.

• FDA approval · 2009-10-15
  FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for clonazepam filed by Teva Pharmaceuticals USA, Inc., indicating an update under the approved …